Eli Lilly vs. Novo Nordisk: Fortunes Diverge for the Weight-Loss Drug Titans - The Wall Street Journal
The weight-loss drug market is booming but the spoils aren’t being shared equally.Shares of Eli Lilly jumped more than 10% Wednesday.That came after the company reported better-than-expected quarterly sales and earnings, fueled by soaring sales of weight-loss…
Comments